页 1 从 33 结果
FIELD OF THE INVENTION
The present invention relates to a nutrient pharmaceutical formulation and its use for the treatment of cancer. More specifically, the present invention relates to polyphenol containing pharmaceutical formulations having an effective amount of polyphenols for the treatment of
This is a national stage of PCT/IB05/002107 filed Jul. 21, 2005 and published in English.
The medicinal properties of Chinese green tea (Camellia sinensis) have been known since antiquity. Based on present-day medical knowledge, tea possesses numerous beneficial properties among which are
FIELD OF THE INVENTION
The present invention relates to polyphenol esters derived from green and black teas, and analogs thereof, which are potent inhibitors of the growth of cancerous cells. Specifically, the invention relates to polyphenol esters that inhibit chymotrypsin-like, but not
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of pharmacology and tumor biology. More specifically, the present invention relates to secretion of nucleoside diphosphate kinase (NDPK) from human tumors and the effects of inhibiting
The invention relates to a process for extracting one or more polyphenols from fruits such as apples and to uses of said extracts in the treatment or prophylaxis of cardiovascular disease, colon cancer and digestive health.
Cardiovascular disease (CVD) and cancer are two leading causes of death
The present invention relates to the use of cocoa polyphenols for treating prostate hyperplasia, to a specific cocoa extract and to the uses of said extract in the pharmaceutical and food sectors.
The invention more specifically relates to the use of cocoa polyphenols for preventively or curatively
FIELD OF THE INVENTION
The present invention relates to compositions comprising a combination of at least one source of .delta.-tocols (tocotrienol and/or tocopherol), with an antioxidant source comprising polyphenolic compounds. Due to synergistic effects, such compositions are useful in treating
FIELD OF THE INVENTION
The field of the invention is pharmaceutical agents for treatment and chemoprevention of neoplastic diseases.
BACKGROUND OF THE INVENTION
Green tea extracts and their isolated constituents have been described in numerous reports as antineoplastic agents. For example, U.S. Pat.
1. INTRODUCTION
The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and
1. INTRODUCTION
The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and
1. INTRODUCTION
The present invention relates to novel methods and sustained release compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
REFERENCE TO SEQUENCE LISTING, A TABLE, OR A COMPUTER PROGRAM LISTING COMPACT DISK APPENDIX
Not Applicable
BACKGROUND OF THE INVENTION
The present invention relates to novel methods and compositions which utilize
FIELD OF THE INVENTION
The invention relates to the pharmaceutical field, concretely to the combined use of 2 active principles, pterostilbene and quercetin, in the manufacture of medicinal products that can be used for cancer treatment.
STATE OF THE ART
Various phenolic compounds, including
RELATED APPLICATIONS/INCORPORATION BY REFERENCE
All documents cited or referenced herein ("herein cited documents"), and all documents cited or referenced in the herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any
BACKGROUND OF INVENTION
The proteasome is a massive multi-catalytic protease complex that is responsible for degrading the majority of cellular proteins. The 20S-core particle of the 26S proteasome is barrel-shaped, and the sites of proteolytic activity reside on the interior.
The eukaryotic